Dr.  Jean Charron is an investigator at the Research Centre of the CHU of Québec-Université Laval in the Oncology axis. He is also Professor at the Department of molecular biology, medical biochemistry and pathology in the Faculty of medicine at Université Laval. His research activities focus on the functional characterization of the decision-making mechanisms of the ERK/MAPK signaling pathway in cells when exposed to developmental or environmental cues. These mechanisms are essential for embryonic development and homeostasis of every living throughout life.  Any failure of interpretation of cell signalling leads to malformations or pathologies.

Role of the ERK/MAPK pathway in lung development

The development of the respiratory tract is complex and requires several steps of morphogenesis, differentiation and maturation to form the definitive lung. The integration of signals induces by the interaction of secreted factors with their receptors or by cell-cell interactions is essential for lung formation. Dr. Charron’s laboratory examines the role of the ERK/MAPK pathway in lung development using the mouse as a model.  His team has already highlighted the role of the ERK/MAPK pathway in lung morphogenesis during bronchial branching and the formation of tracheal cartilage. These defects faithfully recapitulate the phenotypes of significant and costly human diseases, including lung hypoplasia, lung agenesis and tracheomalacia, each representing a major public health concern. These studies will play an increasingly important role in providing insights into the molecular mechanisms underlying fetal and neonatal diseases and in allowing development of novel targeted therapies.

Role of the ERK/MAPK path in the development of autoimmune diseases

The work of the team of Dr. Charron has also shown that decreased ERK/MAPK signaling in hematopoietic cells causes the abnormal production of autoantibodies directed against nuclear proteins and DNA double strand in mice. Over time, these mice develop a glomerulonephritis leading to kidney failure and severe anemia. These symptoms are similar to those of systemic lupus erythematosus (SLE), a severe auto-immune disease more frequent in women than in men. In the murine model generated in the laboratory of Dr. Charron, the females are also 5 times more likely to develop the disease than males. Work is in progress in Dr. Charron’s laboratory to identify which immune cell types are involved in the onset of the auto-immune disease and which molecular mechanisms are involved. This study will provide understanding of the molecular processes leading to the development of autoimmune diseases, and will eventually lead to new therapeutic approaches adapted to sex.

L'Hôtel-Dieu de Québec
9, rue McMahon
1784
Québec, Québec
Canada G1R 2J6
56 entries « 1 of 6 »

Beuret L, Fortier-Beaulieu SP, Rondeau V, Roy S, Houde N, Balabanian K, Espéli M, Charron J

and Functional Redundancy in Erythropoiesis.

Journal Article

Front Cell Dev Biol, 9 , 2021.

Abstract | Links:

Li K, Wu H, Wang A, Charron J, Mishina Y, Habib SL, Liu H, Li B

mTOR signaling regulates gastric epithelial progenitor homeostasis and gastric tumorigenesis via MEK1-ERKs and BMP-Smad1 pathways.

Journal Article

Cell Rep, 35 (5), 2021.

Abstract | Links:

Ikushima YM, Awazawa M, Kobayashi N, Osonoi S, Takemiya S, Kobayashi H, Suwanai H, Morimoto Y, Soeda K, Adachi J, Muratani M, Charron J, Mizukami H, Takahashi N, Ueki K

MEK/ERK Signaling in β-Cells Bifunctionally Regulates β-Cell Mass and Glucose-Stimulated Insulin Secretion Response to Maintain Glucose Homeostasis.

Journal Article

Diabetes, 70 (7), 2021.

Abstract | Links:

Wu H, He D, Biswas S, Shafiquzzaman M, Zhou X, Charron J, Wang Y, Nayak BK, Habib SL, Liu H, Li B

mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK.

Journal Article

Cancer Res, 81 (12), 2021.

Abstract | Links:

Long ME, Gong KQ, Eddy WE, Volk JS, Morrell ED, Mikacenic C, West TE, Skerrett SJ, Charron J, Liles WC, Manicone AM

MEK1 regulates pulmonary macrophage inflammatory responses and resolution of acute lung injury.

Journal Article

JCI Insight, 4 (23), 2019.

Abstract | Links:

Talwar H, Bouhamdan M, Bauerfeld C, Talreja J, Aoidi R, Houde N, Charron J, Samavati L

MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression.

Journal Article

J Immunol, 202 (6), 2019.

Abstract | Links:

Aoidi R, Houde N, Landry-Truchon K, Holter M, Jacquet K, Charron L, Krishnaswami SR, Yu BD, Rauen KA, Bisson N, Newbern J, Charron J

mice recapitulate aspects of human cardio-facio-cutaneous syndrome.

Journal Article

Dis Model Mech, 11 (3), 2018.

Abstract | Links:

Choi J, Huebner AJ, Clement K, Walsh RM, Savol A, Lin K, Gu H, Di Stefano B, Brumbaugh J, Kim SY, Sharif J, Rose CM, Mohammad A, Odajima J, Charron J, Shioda T, Gnirke A, Gygi S, Koseki H, Sadreyev RI, Xiao A, Meissner A, Hochedlinger K

Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells.

Journal Article

Nature, 548 (7666), 2017.

Abstract | Links:

Long ME, Eddy WE, Gong KQ, Lovelace-Macon LL, McMahan RS, Charron J, Liles WC, Manicone AM

MEK1/2 Inhibition Promotes Macrophage Reparative Properties.

Journal Article

J Immunol, 198 (2), 2017.

Abstract | Links:

Boucherat O, Landry-Truchon K, Aoidi R, Houde N, Nadeau V, Charron J, Jeannotte L

Lung development requires an active ERK/MAPK pathway in the lung mesenchyme.

Journal Article

Dev Dyn, 246 (1), 2017.

Abstract | Links:

56 entries « 1 of 6 »
Signaler des ajouts ou des modifications

Active projects

  • Role of the ERK/MAPK pathway in intestine development and homeostasis., from 2016-04-01 to 2022-03-31
Data provided by the Université Laval research projects registery